Changes in the Metabolic Parameters and QTc Interval After Switching From Olanzapine to Aripiprazole in Japanese Patients With Stable Schizophrenia

被引：8

作者：

Suzuki, Yuatro ^{[1
]}

Sugai, Takuro ^{[1
]}

Ono, Shin ^{[1
]}

Sawamura, Kazushi ^{[1
]}

Fukui, Naoki ^{[1
]}

Watanabe, Junzo ^{[1
]}

Tsuneyama, Nobuto ^{[1
]}

Someya, Toshiyuki ^{[1
]}

机构：

[1] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2011年 / 31卷 / 04期

关键词：

INDUCED HYPERPROLACTINEMIA; SCHIZOAFFECTIVE DISORDER; TERM;

D O I：

10.1097/JCP.0b013e318221e80d

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：526 / 528

页数：3

共 12 条

[1] Similar frequency of abnormal correlation between serum leptin levels and BMI before and after olanzapine treatment in schizophrenia [J].

Baptista, Trino ;

Davila, Adriana ;

El Fakih, Yamily ;

Uzcategui, Euderruh ;

Rangel, Nairy N. ;

Olivares, Yamile ;

Galeazzi, Tatiana ;

Vargas, Doritza ;

Pena, Rocio ;

Marquina, David ;

Villarroel, Vanesa ;

Teneud, Luis ;

Beaulieu, Serge .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (04) :205-211

[2] Hormonal Markers of Metabolic Dysregulation in Patients With Severe Mental Disorders After Olanzapine Treatment Under Real-Life Conditions [J].

Birkenaes, Astrid B. ;

Birkeland, Kare I. ;

Friis, Svein ;

Opjordsmoen, Stein ;

Andreassen, Ole A. .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (02) :109-116

[3] Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine [J].

Chrzanowski, Wlodzimierz K. ;

Marcus, Ronald N. ;

Torbeyns, Anne ;

Nyilas, Margaretta ;

McQuade, Robert D. .

PSYCHOPHARMACOLOGY, 2006, 189 (02) :259-266

[4] Neuroleptic-induced hyperprolactinemia [J].

Dickson, RA ;

Glazer, WM .

SCHIZOPHRENIA RESEARCH, 1999, 35 :S75-S86

[5]

FRAGUAS D, 2010, EUR NEUROPSYCHOPHARM

[6] A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder [J].

Hanssens, Linda ;

van Winkel, Ruud ;

Wampers, Martien ;

Van Eyck, Dominique ;

Scheen, Andre ;

Reginster, Jean-Yves ;

Collette, Julien ;

Peuskens, Joseph ;

De Hert, Marc .

SCHIZOPHRENIA RESEARCH, 2008, 106 (2-3) :308-314

[7] Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. [J].

Marder, SR ;

McQuade, RD ;

Stock, E ;

Kaplita, S ;

Marcus, R ;

Safferman, AZ ;

Saha, A ;

Ali, M ;

Iwamoto, T .

SCHIZOPHRENIA RESEARCH, 2003, 61 (2-3) :123-136

[8] Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics [J].

Osuntokun, Olawale ;

Millen, Brian ;

Xu, Wen I. ;

Kryzhanovskaya, Ludmilla A. ;

Robertson-Plouch, Carol ;

Carlson, Janice L. ;

Acharya, Nayan ;

Corya, Sara A. .

JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (05) :630-638

[9] Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: A placebo-controlled 26-week study [J].

Pigott, TA ;

Carson, WH ;

Saha, AR ;

Torbeyns, AF ;

Stock, EG ;

Ingenito, GG .

JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (09) :1048-1056

[10] Adjunctive treatment with a dopamine partial agonist, aripiprazole, for anti psychotic-induced hyperprolactinemia: A placebo-controlled trial [J].

Shim, Joo-Cheol ;

Shin, Jae-Goo K. ;

Kelly, Deanna L. ;

Jung, Do-Un ;

Seo, Young-Soo ;

Liu, Kwang-Hyeon ;

Shon, Ji-Hong ;

Conley, Robert R. .

AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (09) :1404-1410

← 1 2 →